medigraphic.com

2021, Número 1

<< Anterior Siguiente >>

Enf Infec Microbiol 2021; 41 (1)


Diagnóstico serológico de la infección por el virus c de la hepatitis (parte I)

González GYJ, García RI, García FWO

Idioma: Español
Referencias bibliográficas: 40
Paginas: 28-34
Archivo PDF: 219.63 Kb.


RESUMEN

Las pruebas serológicas se han convertido en herramientas fundamentales en el diagnóstico y manejo de la infección por el virus de la hepatitis c (VHC). Estas pruebas incluyen la detección de anticuerpos contra el VHC en suero, la detección y cuantificación del ARN-VHC, así como la determinación del genotipo del VHC en suero. Estas pruebas son fundamentales en el diagnóstico y manejo terapéutico de la hepatitis c. En este artículo hacemos una revisión exhaustiva del tema.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Crespo, M.P. “El diagnóstico viral por el laboratorio”, Colombia Medica, 2000, 31 (3).

  2. Hino, K., Sainokami, S., Shimoda, K., Niwa, H. y Lino, S., “Clinical course of acute hepatitis c and changes in hcv markers, Dig Dis Sci, 1994, 39: 19-27.

  3. Farci, P., Alter, H.J., Wong, D., Miller, R.H., Shih, J.W., Jett, B. y Purcell, R.H., “A long-term study of hepatitis c virus replication in non-a, non-b hepatitis”, N Engl J Med, 1991, 325: 98-104.

  4. Puoti, M., Zonaro, A., Ravaggi, A., Marin, M.G., Castelnuovo, F. y Cariani, E., “Hepatitis c virus rna and antibody response in the clinical course of acute hepatitis c virus infection”, Hepatology, 1992, 16: 887-881.

  5. Pawlotsky, J.M., “Use and interpretation of virological tests for hepatitis c”, Hepatology, 2002, 36 (5): s65-s73.

  6. Bukh, J., Miller, R.H. y Purcell, R.H., “Genetic heterogeneity of hepatitis c virus: quasispecies and genotypes”, Semin Liver Dis, 1995, 1 (15): 41-63.

  7. Padrón, G.J., Arus, E., Morales, J., Muzio, V., Penton, E., Mas, P., Sariol, C.A. et al., Bases moleculares para el estudio de las hepatitis virales, La Habana, Elfos Scientiae, 1998, pp. 161-184.

  8. Carey, W., “Tests and screening strategies for the diagnosis for hepatitis c, Cleveland Clin J Medicine, 2003, 70 (4): 7-13.

  9. umelisa® hcv 3ª Generación para la detección de anticuerpos al vhc en suero, plasma y sangre seca sobre papel de filtro, “Instructivo del ensayo”, cie, 2000.

  10. National Institutes of Health (nih), “Consensus and state of the science statements”, Statement on Management of Hepatitis c, 2002, 19 (3).

  11. Hoofnagle, J.H., “Course and outcome of hepatitis c”, Hepatology, 2002, 36: 21-29.

  12. Colin, C., Lanoir, D., Touzet, S., Meyaud-Kraemer, L., Bailly, F. y Trepo, C., “Sensitivity and specificity of third-generation hepatitis c virus antibody detection assays: an analysis of the literature”, J Viral Hepat, 2001, 8: 87-95.

  13. ImmunoComb® ii hcv kit: a rapid test for the qualitative detection of igg antibodies to hepatitis c virus (hcv) in human serum or plasma, Code: 60455002, Orgenics.

  14. Bassit, L., Van Heuverswyn, H., De Bosschere ,K., Nishiya, A.S. et al., Comparative study of two anti-hcv screening tests in a large genotyped population of Brazilian dialysis patients”, Eur J Clin Microbiol Infect Dis, 2002, 21: 404-406.

  15. } Maertens, G., Vorsters, A., Royens, B., Dekeyser, F. y Zrein, M., “A fourth generation assay for the screening of hcv antibodies”, Hepatitis Program, Innogenetics nv, presentada en la European Association for the Study of the Liver, 34th Annual Meeting, Nápoles, Italia, 8-12 de abril de 1999.

  16. Skidmore, S., “Recombinant immunoblot assay for hepatitis c antibody”, The Lancet, 1990, 335 (8701): 1346.

  17. Van der Poel, C.L., Cuypers, H.T.M., Reesink, H.W. et al., “Confirmation of hepatitis c virus infection by new fourantigen recombinant immunoblot assay”, The Lancet, 1991, 337 (8737): 317-319.

  18. Alter, H.J., Tegtmeier, G.E., Jett, B.W. et al., “The use of a re-combinant immunoblot assay in the interpretation of anti-hepatitis c virus reactivity among prospectively followed patients, implicated donors, and random donors”, Transfusion, 1991, 31 (8): 771-776.

  19. lia tek hcv iii, Organon Teknika, B.V., Holanda.

  20. Ortiz-Ibarra, F.J., Figueroa-Damián, R., Lara-Sánchez, J., Arredondo-García, J.L. y Ahued-Ahued, J.R., “Prevalencia de marcadores serológicos de los virus de la hepatitis a, b, c y d en embarazadas”, Salud Pública Mex, 1996, 38: 317-322.

  21. Picazo, J.J. y Fuertes, A., “Diagnóstico serológico de la hepatitis c”, Protocolos de Diagnóstico Serológico Clínico, 5, dsc.

  22. Dutra Souto, F.J., Fernandes Fontes, J. y Coimbra Gaspar, A.M., “Prevalence of Hepatitis b and c virus markers among malaria-exposed gold miners in Brazilian Amazon”, Mem Inst Oswaldo Cruz, 2001, 96.

  23. Pawlotsky, J.M., Prescott, L., Simmonds, P., Pellet, C., Laurent-Puig, P., Labonne, C., Darthuy, F. et al., “Serological determination of hepatitis c virus genotype: comparison with a standardized genotyping assay”, J Clin Microbiol, 1997, 35: 1734-1739.

  24. Courouce, A.M., Le Marrec, N., Bouchardeau, F., Razer, A., Maniez, M., Laperche, S. y Simon, N., “Efficacy of hcv core antigen detection during the preseroconversion period”, Transfusion, 2000, 40: 1198-1202.

  25. Lee, S.R., Peterson, J., Niven, P., Bahl, C., Page, E., De- Leys, R,. Giordano-Schmidr, D. et al., “Efficacy of a hepatitis c virus core antigen enzyme-linked immunosorbent assay for the identification of ‘window-phase’ blood donations, Vox Sang, 2001, 80: 19-23.

  26. Bouvier, A.M., Patel, K., Dahari, H., Beaucourt, S., Larderie, P., Blatt, L., Hezode, C, et al., “Clinical utility of total hepatitis c virus (hcv) core antigen quantification, a new indirect marker of hcv replication”, Hepatology, 2002, 36: 211-218.

  27. Miyachi, H. et al., “Monitoring of inhibitors of enzymatic amplification in polymerase chain reaction and evaluation of efficacy of rna extraction for the detection of hepatitis c virus using the internal control”, Clin Chem Lab Med, 1998, 36 (8): 571-575.

  28. Busch, M.P., Wilber, J.C., Johnson, P., Tobler, L. y Evans, C.S., “Impact of specimen handling and storage on detection of hepatitis c virus rna”, Transfusion, 1992, 32: 420-425.

  29. Tang, Y.W., Procop, G.W. y Persing, D.H., “Molecular diagnosis of infectious diseases”, Clin Chemistry, 1997, 43 (11): 2021-2038.

  30. González, Y.J., González, I., Vina, A., Armas, A., García, I. y Solís, R.L., “Desarrollo de un sistema de diagnóstico molecular para la detección cualitativa del arn del virus de la hepatitis c”, Biotecnología Aplicada, 2003, 20 (2): 122-125.

  31. González, I., Vina, A., Armas, A., García, I. y González, Y.J., “Design of an antisense rt-pcr primer efficient for all hepatitis c virus genotypes. Comparison of its performance vs. a commercial primer”, Analytical Biochemistry, 2003, 315 (2): 281-284.

  32. González, I., González, Y.J., Armas, A., Vina, A. et al., “Validation of a nested pcr assay umelosa® hcv Cualitativo for detection of hepatitis c virus”, Biologicals, 2003, 31 (1): 55-61.

  33. González, I., González, Y.J., Vina, A., Armas, A. y Solís, R.L., “The usefulness of umelosa hepatitis c virus qualitative kit as supplemental test for confirmation of hepatitis c virus infection”, Revista da Sociedad Brasileira de Medicina Tropical, 2004, 37: 25-27.

  34. Mullis, K.B. y Faloona, F.A., “Specific synthesis of dna in vitro via a polymerase-catalyzed chain reaction”, Methods Enzymol, 1987, 155: 335-350.

  35. Saiki, R.K., Gelfand, D.H., Stoffel, S. et al., “Primer-directed enzimatic amplification of dna with a thermostable dna polymerase”, Science, 1988, 239: 487-491.

  36. Compton, J., “Nucleic acid sequence-based amplification”, Nature, 1991, 350: 91-92.

  37. Guatelli, J.C., Whitefield, K.M., Chappelle, H.L., Di Michelle, L.J. et al., “Isothermal in vitro amplification of nucleic acids by multienzyme reaction modeled after retroviral replication”, Proc Natl Acad Sci USA, 1990, 87: 1874-1878.

  38. Lok, A.S.F. y Gunaratnan, N.T., “Diagnosis of hepatitis c”, Hepatology, 1997.

  39. Collins, M.L., Zayati, C., Detmer, J., Daly Kolberg, J., Chang, C., Irvine, I., Tucker, J. y Urdea, M.S., “Preparation and characterization of rna standards for use in quantitative branched dna hybridization assays”, Anal Biochem, 1995, 226: 120-129.

  40. Collins, M.L., Irvine, I., Tyner, D., Fine, E., Zayati, C., Chang, C., Horn, T., Ahle, D., Detmer, J., Shen, L.P., Kolberg, J., Bushnell, S., Urdea, M.S. y Ho, D.D., “A branched dna signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml”, Nucleic Acids Rcs, 1997, 25: 2979-2984.




2020     |     www.medigraphic.com